UB Paderborn / Katalog / Suche / in CDI

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Nature communications, 2022-02, Vol.13 (1), p.857-12, Article 857

2022

Volltextzugriff (PDF)

Human Gut Microbiota and Gastrointestinal Cancer

Genomics, proteomics & bioinformatics, 2018-02, Vol.16 (1), p.33-49

2018

Volltextzugriff (PDF)

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma

BMC cancer, 2022-02, Vol.22 (1), p.197-197, Article 197

2022

Volltextzugriff (PDF)

The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts

Cell death & disease, 2021-03, Vol.12 (4), p.291-291, Article 291

2021

Volltextzugriff (PDF)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease

Frontiers in oncology, 2021-02, Vol.11, p.625872-625872

2021

Volltextzugriff (PDF)

Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.1758835920922028-1758835920922028

2020

Volltextzugriff (PDF)

Improvement of hydrogen production performance by in situ doping of carbon nanotubes into TiO2 materials

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2022-03, Vol.24 (3), Article 61

2022

Volltextzugriff (PDF)

Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors

Clinical and experimental medicine, 2023-11, Vol.23 (7), p.3907-3918

2023

Volltextzugriff (PDF)

Investigation of Creep Behavior of HDPE Pipe Butt Fusion Welded Joints Using a Stepped Isostress Method

Polymers, 2024-06, Vol.16 (13), p.1803

2024

Volltextzugriff (PDF)

Dependence Analysis of PM2.5 Concentrations in 295 Chinese Cities in the Winter of 2019–2020

Atmosphere, 2022-11, Vol.13 (11), p.1847

2022

Volltextzugriff (PDF)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2020-07, Vol.10, p.1098-1098

2020

Volltextzugriff (PDF)

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma

BMC cancer, 2023-10, Vol.23 (1), p.958-958, Article 958

2023

Volltextzugriff (PDF)

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)

Frontiers in oncology, 2021-07, Vol.11, p.684867-684867

2021

Volltextzugriff (PDF)

Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.1758835920975353-1758835920975353

2020

Volltextzugriff (PDF)

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Frontiers of medicine, 2022-10, Vol.16 (5), p.773-783

2022

Volltextzugriff (PDF)

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer

Frontiers in oncology, 2021-12, Vol.11, p.781697-781697

2021

Volltextzugriff (PDF)

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

Frontiers in oncology, 2023-06, Vol.13, p.1167213-1167213

2023

Volltextzugriff (PDF)

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma

Canadian respiratory journal, 2022, Vol.2022, p.1-12

2022

Volltextzugriff (PDF)

A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE

European journal of nuclear medicine and molecular imaging, 2022-04, Vol.49 (5), p.1613-1622

2022

Volltextzugriff (PDF)

MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma

BMC cancer, 2014-08, Vol.14 (1), p.616-616, Article 616

2014

Volltextzugriff (PDF)

Research status and challenges of plant-derived exosome-like nanoparticles

Biomedicine & pharmacotherapy, 2024-05, Vol.174, p.116543-116543, Article 116543

2024

Volltextzugriff (PDF)

Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data

Neoplasia (New York, N.Y.), 2022-12, Vol.34, p.100841, Article 100841

2022

Volltextzugriff (PDF)

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial

Cancer medicine (Malden, MA), 2021-03, Vol.10 (5), p.1681-1689

2021

Volltextzugriff (PDF)

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades

Endocrine Connections, 2023-04, Vol.12 (4), p.1-14

2023

Volltextzugriff (PDF)

Mesenchymal stem cells derived from adipose accelerate the progression of colon cancer by inducing a MT-CAFs phenotype via TRPC3/NF-KB axis

Stem cell research & therapy, 2022-07, Vol.13 (1), p.1-335, Article 335

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Human Gut Microbiota and Gastrointestinal Cancer

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma

The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease

Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review

Improvement of hydrogen production performance by in situ doping of carbon nanotubes into TiO2 materials

Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors

Investigation of Creep Behavior of HDPE Pipe Butt Fusion Welded Joints Using a Stepped Isostress Method

Dependence Analysis of PM2.5 Concentrations in 295 Chinese Cities in the Winter of 2019–2020

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)

Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma

A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE

MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma

Research status and challenges of plant-derived exosome-like nanoparticles

Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades

Mesenchymal stem cells derived from adipose accelerate the progression of colon cancer by inducing a MT-CAFs phenotype via TRPC3/NF-KB axis

Suchergebnisse filtern